Gary W. Cole, MD, FAAD
Dr. Cole is board certified in dermatology. He obtained his BA degree in bacteriology, his MA degree in microbiology, and his MD at the University of California, Los Angeles. He trained in dermatology at the University of Oregon, where he completed his residency.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- Psoriasis facts
- What is psoriasis?
- What are psoriasis causes and risk factors?
- What are the different types of psoriasis?
- Can psoriasis affect my joints?
- Can psoriasis affect only my nails?
- What are psoriasis symptoms and signs? What does psoriasis look like?
- How do health care professionals diagnose psoriasis?
- Eczema vs. psoriasis
- How many people have psoriasis?
- Is psoriasis contagious?
- Is there a cure for psoriasis?
- Is psoriasis hereditary?
- What health care specialists treat psoriasis?
- What are psoriasis treatment options?
- What creams, lotions, and home remedies are available for psoriasis?
- Are psoriasis shampoos available?
- What oral medications are available for psoriasis?
- What injections or infusions are available for psoriasis?
- Is there a psoriasis diet?
- What about light therapy for psoriasis?
- What is the long-term prognosis with psoriasis? What are complications of psoriasis?
- Is it possible to prevent psoriasis?
- What does the future hold for psoriasis?
- Is there a national psoriasis support group?
- Where can people get more information on psoriasis?
- Psoriasis FAQs
- Find a local Dermatologist in your town
What is the long-term prognosis with psoriasis? What are complications of psoriasis?
Overall, the prognosis for most patients with psoriasis is good. While it is not curable, it is controllable. As described above, recent studies show an association of psoriasis and other medical conditions, including obesity and heart disease.
Is it possible to prevent psoriasis?
Since psoriasis is inherited, it is impossible at this time to suggest anything that is likely to prevent its development aside from indulging in a healthy lifestyle.
What does the future hold for psoriasis?
Psoriasis research is heavily funded and holds great promise for the future. Just the last five to 10 years have brought great strides forward in treatment of the disease with medications aimed at treating the overactive immune system that causes the skin inflammation of psoriasis. Ongoing research is needed to decipher the ultimate underlying cause of this disease.
Is there a national psoriasis support group?
Yes, the National Psoriasis Foundation (NPF) is an organization dedicated to helping patients with psoriasis and furthering research in this field. They hold national and local chapter meetings. The NPF web site (http://www.psoriasis.org/home/) shares up-to-date reliable medical information and statistics on the condition.
Where can people get more information on psoriasis?
There are many ongoing clinical trials for psoriasis all over the United States and in the world. Many of these clinical trials are ongoing at academic or university medical centers and are frequently open to patients without cost.
Clinical trials frequently have specific requirements for types and severity of psoriasis that may be enrolled into a specific trial. Patients need to contact these centers and inquire regarding the specific study requirements. Some studies have restrictions on what recent medications have been used for psoriasis, current medication, and overall health.
Some of the many medical centers in the U.S. offering clinical trials for psoriasis include the University of California, San Francisco Department of Dermatology, the University of California, Irvine Department of Dermatology, and the St. Louis University Medical School.
Alwan, W., and F.O. Nestle. "Pathogenesis and Treatment of Psoriasis: Exploiting Pathophysiological Pathways for Precision Medicine." Clin Exp Rheumatol 33 (Suppl. 93): S2-S6.
Arndt, Kenneth A., eds., et al. "Topical Therapies for Psoriasis." Seminars in Cutaneous Medicine and Surgery 35.2S Mar. 2016: S35-S46.
Dowlatshahi, E.A., E.A.M van der Voort, L.R. Arends, and T. Nijsten. "Markers of Systemic Inflammation in Psoriasis: A Systematic Review and Meta-Analysis." British Journal of Dermatology 169.2 Aug. 2013: 266–282.
Villaseñor-Park, Jennifer, David Wheeler, and Lisa Grandinetti. "Psoriasis: Evolving Treatment for a Complex Disease." Cleveland Clinic Journal of Medicine 79.6 June 2012: 413-423.
Find out what women really need.